Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood Group O Does Not Increase the Risk of Inhibitors in Severe Haemophilia A: Data from the PedNet Study Group.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

Hemophilia B Leyden: characteristics and natural history in the International Pediatric Network of Hemophilia Management Registry.

Journal of thrombosis and haemostasis : JTH·2025
Same author

BAY 81-8973 Demonstrates Long-Term Safety and Efficacy in Children With Severe Haemophilia A: Results From the LEOPOLD Kids Extension Study.

European journal of haematology·2024
Same author

Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B.

Haemophilia : the official journal of the World Federation of Hemophilia·2024
Same author

Prophylactic Treatment of Children with Hemophilia in Sweden.

Seminars in thrombosis and hemostasis·2024
Same author

Recombinant factor IX Fc for the treatment of hemophilia B.

European journal of haematology·2024

Related Experiment Video

Updated: Jul 16, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

The thalassaemia syndromes.

Henrik Birgens1, Rolf Ljung

  • 1Department of Haematology, Herlev University Hospital, Herlev, Denmark. hebi@herlevhosp.kbhamt.dk

Scandinavian Journal of Clinical and Laboratory Investigation
|March 17, 2007
PubMed
Summary

Thalassaemia, a common hereditary blood disorder, affects millions globally. This article details its biological and clinical aspects, crucial for healthcare professionals, especially in non-endemic regions like the Nordic countries.

Area of Science:

  • Genetics and Hereditary Diseases
  • Hematology
  • Public Health

Background:

  • Thalassaemia syndromes are prevalent hereditary blood disorders globally, particularly in Mediterranean, Middle Eastern, and Asian regions.
  • Recent population migration has increased thalassaemia frequency in non-endemic areas.
  • Homozygous thalassaemia is rare in Nordic countries, leading to unfamiliarity among healthcare providers.

Purpose of the Study:

  • To elucidate the biological underpinnings of thalassaemia.
  • To describe the clinical manifestations and management of thalassaemia.
  • To enhance awareness and understanding of thalassaemia among healthcare professionals in regions where it is less common.

Main Methods:

  • Review of existing literature on thalassaemia.

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Related Experiment Videos

Last Updated: Jul 16, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

  • Synthesis of biological mechanisms.
  • Compilation of clinical data and patient case studies.

    • Main Results:

    • Detailed explanation of the genetic basis of various thalassaemia types.
    • Description of the spectrum of clinical symptoms, from mild to severe.
    • Highlighting the diagnostic challenges and treatment options.

    Conclusions:

    • Thalassaemia is a significant global health concern requiring increased awareness.
    • Understanding the biological and clinical aspects is vital for accurate diagnosis and effective patient care.
    • Education for healthcare professionals in non-endemic areas is essential for managing the increasing prevalence of thalassaemia.